Nivolumab is a new Therapy Option for metastasized Renal Cell Carcinoma Results of the Phase-III-Study CheckMate 025-MedSci.cn

Nivolumab is a new Therapy Option for metastasized Renal Cell Carcinoma Results of the Phase-III-Study CheckMate 025

Nuhn, P; Bolenz, C

Nuhn, P (reprint author), Heidelberg Univ, Univ Med Mannheim, Urol Klin, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.

ONKOLOGE, 2017; 23 (3): 232